Trends in Launch Prices and Price Increases for New Medicines for Urological Cancers.

Hwang, Thomas J; Isaac-Wilkins, Symone; Trinh, Quoc-Dien

Hwang, Thomas J; Isaac-Wilkins, Symone; Trinh, Quoc-Dien.

Afiliación

Hwang TJ; Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Isaac-Wilkins S; Cancer Innovation and Regulation Initiative, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Trinh QD; Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

J Urol ; 208(3): 514-516, 2022 09.

Article en En | MEDLINE | ID: mdl-35757920

Asunto(s)

Neoplasias Urológicas; Humanos; Neoplasias Urológicas/tratamiento farmacológico

Palabras clave

Medicare Part D; drug costs; health policy; reimbursement, incentive; urologic neoplasms

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Urológicas Tipo de estudio: Health_economic_evaluation Límite: Humans Idioma: En Revista: J Urol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google